Variant report
Variant | esv3432801 |
---|---|
Chromosome Location | chr10:55338217-55338732 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs183111170 | chr10:55338230-55338231 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs439136 | chr10:55338240-55338241 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs554342892 | chr10:55338244-55338245 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs568177757 | chr10:55338249-55338250 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs530549494 | chr10:55338250-55338251 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs187083045 | chr10:55338266-55338267 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs112370323 | chr10:55338286-55338287 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs141049139 | chr10:55338313-55338314 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs545645812 | chr10:55338318-55338319 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs75251515 | chr10:55338357-55338358 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs550678985 | chr10:55338392-55338393 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs575515060 | chr10:55338401-55338402 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs191933274 | chr10:55338402-55338403 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs182906934 | chr10:55338410-55338411 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs187756782 | chr10:55338422-55338423 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs537849569 | chr10:55338578-55338579 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs570499985 | chr10:55338679-55338680 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs529220560 | chr10:55338714-55338715 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs540818208 | chr10:55338717-55338718 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs554672083 | chr10:55338729-55338730 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs560711150 | chr10:55338732-55338733 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Pancreatic endocrine tumor | 17639061 | CNVD |
Gastric cancer | 17908304 | CNVD |
Chordoma | 21602918 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Melanoma | 18172304 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 20724749 | CNVD |
Autism | 22495311 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Prostate cancer | 18632612 | CNVD |
Autism | 18414403 | CNVD |
Cockayne syndrome | 18421352 | CNVD |
Glioblastoma | 16823260 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Neuroblastoma | 17533364 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Glioma | 21971842 | CNVD |
Cancer | 21637783 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Obesity | 21956041 | CNVD |
Developmental delay | 21948486 | CNVD |
Intellectual disability | 21948486 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21364760 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Autism | 20841430 | CNVD |
Mental retardation | 17124404 | CNVD |
Epilepsy | 20923578 | CNVD |
Prostate cancer | 16573809 | CNVD |
Schizophrenia | 19329560 | CNVD |
Heart failure | 18772530 | CNVD |
Heart failure | 18854381 | CNVD |
Hyperglycemia | 19060297 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Usher syndrome | 20538994 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Autism | 20858243 | CNVD |
Melanoma | 17363583 | CNVD |
Breast cancer | 22522925 | CNVD |
Usher type I cohort | 17277737 | CNVD |
Usher type I cohort | 21436283 | CNVD |
Leukemia | 21357790 | CNVD |
Medulloblastoma | 22832581 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr10:55337800-55338600 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
2 | chr10:55338000-55338400 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
3 | chr10:55338000-55339800 | Enhancers | Fetal Lung | lung |
4 | chr10:55338200-55338400 | Enhancers | Primary hematopoietic stem cells | blood |
5 | chr10:55338400-55339400 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
6 | chr10:55338600-55339000 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
7 | chr10:55338600-55339400 | Enhancers | HUVEC | blood vessel |